Table 2. Distribution of crEVIFs.
| crEVIF detected in CTA | Number of cases | Recorded therapy |
|---|---|---|
| Pleural effusion | 9 | Confirmation of cardiac insufficiency as the underlying cause leading to optimization of therapy (4) |
| Pneumonia (2) | ||
| No follow-up recorded (3) | ||
| Ascites | 9 | Reduction of ascites by drainage and/or drug therapy (3) |
| No follow-up recorded (6) | ||
| Adrenal mass | 7 | Confirmed as primary or metastasis in follow-up CT (4) |
| No follow-up recorded (3) | ||
| Double duct sign | 7 | No follow-up recorded (7) |
| Pulmonary mass | 6 | Confirmed as primary or metastasis in follow-up CT (4) |
| No follow-up recorded (2) | ||
| Hernia | 6 | Surgical intervention for treating an inguinal hernia (1) |
| No follow-up recorded (5) | ||
| Renal cyst (2F) | 5 | No follow-up recorded (5) |
| Urothelial carcinoma | 3 | Surgical intervention and/ or chemotherapy (3) |
| Pneumonia | 2 | Antibiosis (2) |
| Obstructive uropathy | 2 | No follow-up recorded (2) |
| Prostatitis | 1 | Intravenous antibiosis (1) |
| Renal cell carcinoma | 1 | Chemotherapy (1) |
| Ruptured spleen | 1 | Splenectomy (1) |
| Colitis | 1 | Confirmed as ischemic colitis with embolectomy performed as therapy of choice (1) |
| Sigmoid diverticulitis | 1 | Conservative treatment with intravenous antibiosis (1) |
| Hepatocellular carcinoma | 1 | No follow-up recorded (1) |
| Splenomegaly | 1 | No follow-up recorded (1) |
| Pancreatic mass | 1 | No follow-up recorded (1) |
| Hepatic lesion | 1 | No follow-up recorded (1) |
Pleural effusion, ascites and direct or indirect signs of malignancy were the most common crEVIFs in our patient population. Medical records reported subsequent therapies or further examination in 28 cases.